AXL and lobular neoplasia: In a recent biomarker screening study of Caucasian, Hispanic and African American SLE patients [23] as well as a subsequent validation study of Chinese patients [24], serum levels of sAxl could discriminate active renal from active non-renal SLE, supporting the notion that Axl might be a molecule of particular interest in LN.